Alseres Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alseres Pharmaceuticals

ALSE 0.00500

0.0%

Oct 18 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Donald Gravenor who wrote (40)	8/6/1996 12:32:00 AM
From: Jack L. Dlugach	of 975

Most of the money has already been spent on stage 1, 2, and 3 trials for Therafectin and Greenwich seemed to think it was promising; the FDA also said it held promise but wanted further testing in a blind study to complete stage 3 certification. If BLSI completes this study successfully, then this stock is going to be a big winner; the drug companies are all trying to get an effective rheumatoid arthritis treatment and, with Zeneca's investment, Therafectin will probably be taken to market soon after approval. The Altropane and other drugs in the pipeline are pretty promising as well so, even though this is a highly speculative biotech and a very small one to boot, in my estimation it is worth the risk. I paid so little for my initial stock that it looks expensive to me when it goes over 50 cents but I also believe it's worth accumulating. By the way, I thought Canada didn't charge tax on investment and gambling income; it's nice to see the US isn't the only tax ogre out there. You don't pay tax on lottery winnings and stuff like that do you?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next